Follow the Surgical Science Sweden AB stock price and the full directors' dealings record of the company, a publicly traded company based in Finland. Shares trade on the FI market, under the authority of FIN-FSA. Operating in the Health Care sector, Surgical Science Sweden AB has logged 6 insider filings. Market capitalisation: €1.8bn. The latest transaction was disclosed on 23 June 2026 (Purchase). Among the most active insiders: Anna Ahlberg. Every trade is openly available.
6
Insider Decl.
n/a
Thresholds
€400,584
6 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Surgical Science Sweden AB Strong Buy (bullish), based on 5 analysts. Average price target: SEK 60.80.
35Σ signal
Buys €400,584n/a Sells
Fundamental score
Ranked 13,171 of 29,057 companies
54.4
score / 100
Value
44
Quality
65
FCF yld1.1%
Earn yld2.5%
EV/EBITDA14.3x
ROE2.1%
Gross mgn66%
Net mgn6.7%
Debt/EBITDA0.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
6,000 shares@ €3.29360.0012% mcap67.8% of flowTeckningsoptionFI:A003Q216-1
6 of 6 declarations
About Surgical Science Sweden AB
Surgical Science Sweden AB is a company focused on developing surgical simulation solutions. It aims to enhance the training of healthcare professionals through innovative technologies.